Momordica charantia, which is considered to have the potential to control sugar, has attracted the attention of many diabetic patients, but is there any scientific evidence to prove that it can help stabilize blood sugar? The products in the workshop are mixed, how to choose?
According to statistics, there are 2 million people diagnosed with diabetes in Taiwan Province Province, and the number continues to increase by about 30,000 every year. More than 90% of them are type 2 diabetes, and they are younger. Obesity has become a major global public health challenge due to drinking and a modern lifestyle with little activity. According to the survey of the national health department, the prevalence of overweight and obesity among adults in China is 45.4%, and obesity is an important risk factor for type 2 diabetes.
At present, there is no real cure for diabetes. In addition to drug control, we should actively control diet, cooperate with exercise and lose weight. But many patients can't continue or even give up controlling blood sugar, which will lead to serious complications over time.
In recent years, it has become a trend to use natural therapy to assist sugar control. The main target of diabetes is the insulin receptor, so people from all walks of life are constantly looking for natural substances that can act on the insulin receptor to replace insulin. However, due to the complex physiological mechanism, it is difficult to achieve, and many products called plant insulin have not been scientifically verified, resulting in consumers not knowing how to choose.
In view of this, after 10 years of research, manufacturers in Taiwan Province Province finally found an active ingredient with high affinity to human insulin receptor from Momordica charantia, which is called "MCLR BP- 19" internationally. Since 2065,438+03, four scientific researches have been published in international journals.
Study on sugar control effect of patent peptide 19
The human body needs to start the glucose transporter to transport the glucose in the blood to the cells, otherwise it will become hyperglycemia. Dr. Xu Bangkui, a biochemist, said that the patented sequencing peptide 19 (mclRBP- 19) extracted from Momordica charantia L. is a natural substance, which can not only bind with insulin, but also bind with insulin receptor to maintain blood sugar stability. In order to further confirm the effect, we selected 142 patients who received chronic prescription treatment for diabetes, but the drug treatment effect was not satisfactory, and their blood sugar values were between 120 ~ 140. With the original drug unchanged, three months later, a blood test was conducted, and the peptide 19 was sequenced with the patent (mclRBP- 19).
Glycosylated hemoglobin can reflect the average blood sugar concentration of red blood cells during their survival period (average 3 months); "Patients who usually don't pay attention to diet control may have a low blood sugar value measured in the outpatient clinic, but the glycosylated hemoglobin is very high, indicating that blood sugar control has been unstable in the past three months. Dr. Xu Bangkui emphasized that moderate exercise intervention or auxiliary health care measures should be considered when glycosylated hemoglobin is high.
The above research report was published in the international journal Nutrition in 2020. In addition, a double-blind trial with Sun Yat-sen University of Medical Sciences on patients with blood sugar between 160- 180 also confirmed that the patented peptide 19 (mclRBP- 19) can improve the blood sugar index, and the research report will be published soon.
Carefully choose the patent components with scientific basis.
The publication of several research reports has gradually attracted the attention of Momordica charantia, but Dr. Xu Bangkui said that the patented peptide 19 (mclRBP- 19) is an extremely valuable component in Momordica charantia, and it needs specific technology and good production management to obtain the best curative effect. After analysis, the research team found that many advertised momordica charantia or momordica charantia peptide products do not contain this ingredient, but are simply momordica charantia hydrolysate or momordica charantia extract.
Dr. Xu Bangkui reminded diabetic friends to evaluate whether it is necessary to use health care products to help improve blood sugar under the premise of following the doctor's advice. The key is to carefully select the effective components affirmed by empirical research in order to really play its role.